Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKMY2 mRNA | CTD | PMID:22079256 | 17beta-estradiol | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Estradiol affects the expression of ANKMY2 mRNA | CTD | PMID:22574217 | 17beta-estradiol | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of ANKMY2 mRNA | CTD | PMID:31614463 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANKMY2 mRNA | CTD | PMID:21570461 and PMID:24680724 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of ANKMY2 mRNA | CTD | PMID:20188158 | 3-chloropropane-1,2-diol | increases expression | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of ANKMY2 protein | CTD | PMID:34915118 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKMY2 mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of ANKMY2 mRNA | CTD | PMID:18648102 | 5-aza-2'-deoxycytidine | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Decitabine affects the expression of ANKMY2 mRNA | CTD | PMID:23300844 | 6-propyl-2-thiouracil | decreases expression | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ANKMY2 mRNA | CTD | PMID:30047161 | aflatoxin B1 | decreases methylation | ISO | ANKMY2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ANKMY2 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ANKMY2 mRNA | CTD | PMID:33167477 | amitrole | decreases expression | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of ANKMY2 mRNA | CTD | PMID:30047161 | antirheumatic drug | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of ANKMY2 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ANKMY2 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ANKMY2 protein | CTD | PMID:32717239 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | increases expression | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ANKMY2 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ANKMY2 mRNA | CTD | PMID:33221593 | bisphenol F | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKMY2 mRNA | CTD | PMID:28628672 | cadmium dichloride | decreases methylation | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased methylation of ANKMY2 promoter | CTD | PMID:22457795 | calcitriol | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of ANKMY2 mRNA | CTD | PMID:16002434 | CGP 52608 | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ANKMY2 gene] | CTD | PMID:28238834 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of ANKMY2 mRNA | CTD | PMID:37019170 | cisplatin | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ANKMY2 mRNA | CTD | PMID:27594783 | cisplatin | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Cisplatin affects the expression of ANKMY2 mRNA | CTD | PMID:23300844 | copper(II) sulfate | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ANKMY2 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ANKMY2 mRNA | CTD | PMID:20106945 | dexamethasone | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKMY2 mRNA | CTD | PMID:28628672 | dicrotophos | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of ANKMY2 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKMY2 mRNA | CTD | PMID:27188386 | epoxiconazole | decreases expression | EXP | | 6480464 | epoxiconazole results in decreased expression of ANKMY2 mRNA | CTD | PMID:35436446 | flutamide | decreases expression | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of ANKMY2 mRNA | CTD | PMID:24793618 | indometacin | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKMY2 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ANKMY2 protein | CTD | PMID:32959892 | niclosamide | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of ANKMY2 mRNA | CTD | PMID:36318118 | oxaliplatin | multiple interactions | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ANKMY2 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of ANKMY2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ANKMY2 mRNA | CTD | PMID:21420995 | phenobarbital | decreases expression | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | Phenobarbital results in decreased expression of ANKMY2 mRNA | CTD | PMID:30047161 | potassium chromate | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of ANKMY2 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKMY2 mRNA | CTD | PMID:22079256 | quercetin | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ANKMY2 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKMY2 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKMY2 mRNA | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ANKMY2 mRNA | CTD | PMID:34032870 | sulfadimethoxine | decreases expression | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of ANKMY2 mRNA | CTD | PMID:30047161 | tert-butyl hydroperoxide | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of ANKMY2 mRNA | CTD | PMID:15336504 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide analog results in increased expression of ANKMY2 mRNA | CTD | PMID:25111187 | topotecan | multiple interactions | ISO | Ankmy2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ANKMY2 mRNA | CTD | PMID:25729387 | trichostatin A | decreases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ANKMY2 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | ANKMY2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKMY2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ANKMY2 mRNA | CTD | PMID:19101580 more ... | valproic acid | decreases methylation | ISO | ANKMY2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of ANKMY2 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ANKMY2 mRNA | CTD | PMID:25979313 | vorinostat | increases expression | ISO | ANKMY2 (Homo sapiens) | 6480464 | vorinostat results in increased expression of ANKMY2 mRNA | CTD | PMID:22083351 | |